Suppr超能文献

80 岁或 80 岁以上非 ST 段抬高型心肌梗死或不稳定型心绞痛患者的侵入性与保守性策略(Eighty 后研究):一项开放标签随机对照试验。

Invasive versus conservative strategy in patients aged 80 years or older with non-ST-elevation myocardial infarction or unstable angina pectoris (After Eighty study): an open-label randomised controlled trial.

机构信息

Department of Cardiology, Oslo University Hospital, Oslo, Norway; Faculty of Medicine, University of Oslo, Oslo, Norway.

Centre for Biostatistics and Epidemiology, Oslo University Hospital, Oslo, Norway; Centre for Clinical Heart Research, Oslo University Hospital, Oslo, Norway.

出版信息

Lancet. 2016 Mar 12;387(10023):1057-1065. doi: 10.1016/S0140-6736(15)01166-6. Epub 2016 Jan 13.

Abstract

BACKGROUND

Non-ST-elevation myocardial infarction (NSTEMI) and unstable angina pectoris are frequent causes of hospital admission in the elderly. However, clinical trials targeting this population are scarce, and these patients are less likely to receive treatment according to guidelines. We aimed to investigate whether this population would benefit from an early invasive strategy versus a conservative strategy.

METHODS

In this open-label randomised controlled multicentre trial, patients aged 80 years or older with NSTEMI or unstable angina admitted to 16 hospitals in the South-East Health Region of Norway were randomly assigned to an invasive strategy (including early coronary angiography with immediate assessment for percutaneous coronary intervention, coronary artery bypass graft, and optimum medical treatment) or to a conservative strategy (optimum medical treatment alone). A permuted block randomisation was generated by the Centre for Biostatistics and Epidemiology with stratification on the inclusion hospitals in opaque concealed envelopes, and sealed envelopes with consecutive inclusion numbers were made. The primary outcome was a composite of myocardial infarction, need for urgent revascularisation, stroke, and death and was assessed between Dec 10, 2010, and Nov 18, 2014. An intention-to-treat analysis was used. This study is registered with ClinicalTrials.gov, number NCT01255540.

FINDINGS

During a median follow-up of 1·53 years of participants recruited between Dec 10, 2010, and Feb 21, 2014, the primary outcome occurred in 93 (40·6%) of 229 patients assigned to the invasive group and 140 (61·4%) of 228 patients assigned to the conservative group (hazard ratio [HR] 0·53 [95% CI 0·41-0·69], p=0·0001). Five patients dropped out of the invasive group and one from the conservative group. HRs for the four components of the primary composite endpoint were 0·52 (0·35-0·76; p=0·0010) for myocardial infarction, 0·19 (0·07-0·52; p=0·0010) for the need for urgent revascularisation, 0·60 (0·25-1·46; p=0·2650) for stroke, and 0·89 (0·62-1·28; p=0·5340) for death from any cause. The invasive group had four (1·7%) major and 23 (10·0%) minor bleeding complications whereas the conservative group had four (1·8%) major and 16 (7·0%) minor bleeding complications.

INTERPRETATION

In patients aged 80 years or more with NSTEMI or unstable angina, an invasive strategy is superior to a conservative strategy in the reduction of composite events. Efficacy of the invasive strategy was diluted with increasing age (after adjustment for creatinine and effect modification). The two strategies did not differ in terms of bleeding complications.

FUNDING

Norwegian Health Association (ExtraStiftelsen) and Inger and John Fredriksen Heart Foundation.

摘要

背景

非 ST 段抬高型心肌梗死(NSTEMI)和不稳定型心绞痛是老年人住院的常见原因。然而,针对这一人群的临床试验很少,这些患者接受指南治疗的可能性较低。我们旨在研究这一人群是否会从早期介入策略中获益,而不是保守策略。

方法

这是一项开放标签、随机对照的多中心试验,纳入了来自挪威东南部卫生区 16 家医院的 80 岁及以上的 NSTEMI 或不稳定型心绞痛患者,随机分配到介入组(包括早期冠状动脉造影,立即评估经皮冠状动脉介入治疗、冠状动脉旁路移植术和最佳药物治疗)或保守组(仅最佳药物治疗)。中心的协变量和分层因素为纳入医院,采用区组随机化方法,使用不透光的密封信封产生随机数,密封信封上标记连续的纳入编号。主要终点为心肌梗死、紧急血运重建、卒中和死亡的复合终点,评估时间为 2010 年 12 月 10 日至 2014 年 11 月 18 日。采用意向治疗分析。本研究在 ClinicalTrials.gov 注册,编号为 NCT01255540。

结果

在纳入的 2010 年 12 月 10 日至 2014 年 2 月 21 日期间接受中位随访 1.53 年的 229 名患者中,介入组 93 例(40.6%)和保守组 140 例(61.4%)发生主要终点事件(风险比 [HR] 0.53 [95%CI 0.41-0.69],p=0.0001)。有 5 名患者退出介入组,1 名患者退出保守组。主要复合终点的四个组成部分的 HR 分别为:心肌梗死(0.52 [0.35-0.76],p=0.0010)、紧急血运重建(0.19 [0.07-0.52],p=0.0010)、卒中和任何原因导致的死亡(0.60 [0.25-1.46],p=0.2650)。介入组有 4 例(1.7%)严重出血并发症和 23 例(10.0%)轻微出血并发症,而保守组有 4 例(1.8%)严重出血并发症和 16 例(7.0%)轻微出血并发症。

结论

在 80 岁及以上的 NSTEMI 或不稳定型心绞痛患者中,与保守策略相比,介入策略可降低复合事件的发生。随着年龄的增长(调整肌酐和效应修饰后),介入策略的疗效被削弱。两种策略在出血并发症方面无差异。

资金

挪威卫生协会(ExtraStiftelsen)和英格和约翰·弗雷德里克森心脏基金会。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验